🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Kronos Bio, Inc.

Kronos Bio, Inc. logo
Market Cap: Lowest
Employees: Lowest

entospletinib (ENTO)

Kronos Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel cancer therapeutics targeting dysregulated transcription factors. It is developing product candidates like entospletinib for acute myeloid leukemia and KB-0742 for MYC-amplified solid tumors.

Tags: acute myeloid leukemia, biopharmaceutical, cancer therapeutics, solid tumors, transcription factors

Website

About | Contact | Contact | Contact | About | Careers | About

Symbol: KRON

Recent Price: $0.97

Industry: Biotechnology

CEO: Dr. Norbert W. Bischofberger Ph.D.

Sector: Healthcare

Employees: 58

Address: 1300 South El Camino Real, San Mateo, CA 94402

Phone: 650 781 5200

Last updated: 2024-12-31